This is the authors' abstract. We don't add key points for this paper.
Syntheses and molecular structures of the dimeric tin–platinum complex [LSnPtCl2(SMe2)]2 (2), the tin–platinum clusters [{LSnPtCl(SMe2)}2SnCl2)] (3) and [(LSn)3(PtCl2)(PtClSnCl)(LSnOHCl)] (6) (L=MeN(CH2CMe2O−)2), and of the unprecedented tin(II) aminoalkoxide–tin oxide chloride complex [O(SnCl)2⋅(SnL)2] (5) are reported. The compounds were characterized by NMR spectroscopy (1H, 13C, 119Sn, 195Pt), 119Sn Mössbauer spectroscopy (1–3, 6), electrospray ionization mass spectrometry, elemental analyses, and single‐crystal X‐ray diffraction analyses (2⋅CH2Cl2, 3⋅2 C4H8O, 5, 6⋅3CH2Cl2). The tin(II) aminoalkoxide [MeN(CH2CMe2O)2Sn]2 (1) behaves like a neutral ligand, inserts into a Pt−Cl bond, or is involved in rearrangement reactions with the different behavior occurring even within one compound (3, 6). DFT calculations show that the tin–platinum compounds behave like electronic chameleons.
No takes yet. Share an insight, caveat, or question.
Zöller et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: